경피적 전기 신경 자극 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 용도별, 최종 용도별, 지역별 예측(2024-2030년)

Transcutaneous Electrical Nerve Stimulation Market Size, Share & Trends Analysis Report By Product (Portable, Table Top), By Application (2018 - 2030) (Chronic Pain, Acute Pain), By End-use, And Region Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,833,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,318,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,288,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

경피적 전기 신경 자극 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 경피적 전기 신경 자극 시장은 2030년까지 4억 1,948만 달러에 달할 것으로 예측되며, 2024-2030년 CAGR은 3.94%로 성장할 전망입니다.

만성 통증과 스포츠 외상 증가, 노인 인구 증가는 경피적 신경 자극 시장의 성장을 가속하는 주요 요인입니다. 예를 들어 CDC 보고서에 따르면 2019년 미국 성인의 20.4%가 만성 통증을 앓고 있으며, 성인의 7.4%가 고부하 만성 통증(작업 활동 제한)을 앓고 있다고 합니다.

또한 물리치료사들 사이에서 TENS에 대한 선호도가 높아지면서 시장 성장을 더욱 촉진하고 있습니다. 물리치료사들은 임상 및 재택 환자 치료에서 수기 치료에서 근육 자극 장비로 선호도를 옮기고 있습니다. 이는 예측 기간 중 경피적 전기 신경 자극의 성장을 가속할 것으로 예상됩니다.

2020년 COVID-19의 발생은 의료 공급망 혼란, 생산 지연, 노동력 제한 등의 문제로 인해 시장 확대를 적당히 저해하고 있습니다. 그러나 COVID-19 백신의 도입과 국경 봉쇄의 해제는 향후 수년간 경피적 전기 신경 자극 시장에 긍정적인 영향을 미칠 것으로 예상됩니다.

경피적 전기 신경 자극 시장 보고서 하이라이트

• 제품별로 TENS 시장은 휴대용 TENS 장비와 탁상용 TENS 장비로 구분되며, 2023년에는 휴대용 TENS 부문이 시장을 장악했는데, 이는 가정용 장비에 대한 수요 증가와 노인 인구 증가로 인해 움직일 수 없는 환자 풀이 넓어졌기 때문입니다.
• 용도별로 시장은 만성 통증과 급성 통증으로 구분되며, 2023년에는 급성 통증 부문이 가장 큰 점유율을 차지할 것으로 예상됩니다. 급성 통증은 다시 스포츠 부상, 수술 후 통증, 분만 통증, 생리통으로 세분화됩니다.
• 북미 경피적 전기 신경 자극 시장은 2023년 43.36%의 최대 매출 점유율로 세계 시장을 장악할 것이며, 예측 기간 중 그 지위를 유지할 것으로 보입니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 경피적 전기 신경 자극 시장 변수, 동향, 범위

• 시장 계통 전망
  • 보조 시장의 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 시장 기회 분석
  • 시장이 해결해야 할 과제 분석
• 경피적 전기 신경 자극 시장 분석 툴
  • 업계 분석 - Porter의 산업 분석
  • PESTEL 분석

제4장 경피적 전기 신경 자극 시장 : 제품 유형별 추정·동향 분석

• 부문 대시보드
• 세계의 경피적 전기 신경 자극 시장의 변동 분석
• 세계의 경피적 전기 신경 자극 시장의 규모와 동향 분석, 제품 유형별, 2018-2030년
• 휴대용 TEN
• 테이블톱 TEN

제5장 경피적 전기 신경 자극 시장 : 용도별 추정·동향 분석

• 부문 대시보드
• 세계의 경피적 전기 신경 자극 시장의 변동 분석
• 세계의 경피적 전기 신경 자극 시장의 규모와 동향 분석, 용도별, 2018-2030년
• 만성 통증
• 급성 통증

제6장 경피적 전기 신경 자극 시장 : 최종 용도별 추정·동향 분석

• 부문 대시보드
• 세계의 경피적 전기 신경 자극 시장의 변동 분석
• 세계의 경피적 전기 신경 자극 시장의 규모와 동향 분석, 최종 용도별, 2018-2030년
• 병원
• 물리 치료 클리닉
• 재활치료 센터
• 홈케어
• 기타

제7장 경피적 전기 신경 자극 시장 : 지역별 추정·동향 분석, 제품 유형별, 최종 용도별, 용도별

• 지역 대시보드
• 시장 규모와 예측 및 동향 분석, 2018-2030년
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제8장 경쟁 구도

• 시장 참여 기업의 분류
• 주요 기업 개요
  • OMRON CORPORATION
  • ZYNEX MEDICAL
  • NEUROMETRIX, INC.
  • EMS PHYSIO LTD.
  • BIOMEDICAL LIFE SYSTEMS
  • DJO GLOBAL, INC.
  • GLOBUS
  • Beacmed srl
  • Iskra Medical doo
  • Ito Co., Ltd.
• 히트맵 분석/기업 시장 현황 분석
• 2023년 기업 시장 점유율 추정 분석
• 기타 주요 시장 기업 리스트

KSA

영문 목차

영문목차

Transcutaneous Electrical Nerve Stimulation Market Growth & Trends:

The global transcutaneous electrical nerve stimulation market is anticipated to reach USD 419.48 million by 2030, and is expected to grow at a CAGR of 3.94% from 2024 to 2030 according to a new report by Grand View Research, Inc. Rising cases of chronic pain, sports injuries, along with an increasing geriatric population base are some of the major factors driving transcutaneous electrical nerve stimulation market growth. For instance, as per a CDC report, in 2019, 20.4% of adults had chronic pain and 7.4% of adults had high impact chronic pain (limited work activities) in the U.S.

Moreover, the growing preference for TENS among physiotherapists is further aiding in the market growth. Physiotherapists are increasingly shifting their preference from manual techniques to muscle stimulators to treat patients in clinical and at-home settings as they consume less time and are more effective. This is expected to drive the transcutaneous electrical nerve stimulation growth over the forecast period.

The outbreak of COVID-19 in the year 2020 has moderately hampered the market expansion owing to the issues such as the disruption of the medical supply chain, delayed production, and a restricted workforce. However, the introduction of the COVID-19 vaccine, and the lifting of lockdown impositions across the borders, are expected to have a positive impact on the transcutaneous electrical nerve stimulation market in the coming years.

Transcutaneous Electrical Nerve Simulation Market Report Highlights:

• On the basis of product, the TENS market is segmented into portable and tabletop TENS units. In 2023, the portable TENS segment dominated the market due to the growing demand for at-home use devices and the increasing geriatric population, widening the pool of immobile patients.
• On the basis of application, the market is segmented into chronic pain and acute pain. The acute pain segment held the largest share in 2023. Acute pain is further subsegmented into sports injuries, postoperative pain, labor pain, and menstrual pain.
• The North America transcutaneous electrical nerve stimulation market dominated the global market with the largest revenue share of 43.36% in 2023 and is likely to maintain its position over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Transcutaneous Electrical Nerve Stimulation Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising Cases Of Chronic And Acute Pain
    • 3.2.1.2. Ineffectiveness Of Oral Drugs And Low Preference For Surgical Intervention
    • 3.2.1.3. Rising Geriatric Population
    • 3.2.1.4. Rising Demand For Reduced Hospital Stay
    • 3.2.1.5. Increasing Number Of Surgeries
    • 3.2.1.6. Rising Cases Of Anterior Cruciate Ligament (ACL) Tear, Hip Flexor Strain, And Hamstring Strain Among Sports Players
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Adverse Effects Associated With Devices
    • 3.2.2.2. Increased Cost Of Nerve Stimulation Therapy
  • 3.2.3. Market Opportunities Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Transcutaneous Electrical Nerve Stimulation Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Transcutaneous Electrical Nerve Stimulation Market: Product Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Transcutaneous Electrical Nerve Stimulation Market Movement Analysis
• 4.3. Global Transcutaneous Electrical Nerve Stimulation Market Size & Trend Analysis, by Product Type, 2018 to 2030 (USD Million)
• 4.4. Portables Tens
  • 4.4.1. Portables Tens Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Table Top Tens
  • 4.5.1. Table Top Tens Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Transcutaneous Electrical Nerve Stimulation Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Transcutaneous Electrical Nerve Stimulation Market Movement Analysis
• 5.3. Global Transcutaneous Electrical Nerve Stimulation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Chronic Pain
  • 5.4.1. Chronic Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Arthritis
    • 5.4.2.1 Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.3 Back & Neck Pain
    • 5.4.3.1 Back & Neck Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.4 Fibromyalgia
    • 5.4.4.1 Fibromyalgia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.5 Neuropathic Pain
    • 5.4.5.1 Neuropathic Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.6 Others
    • 5.4.6.1 Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Acute Pain
  • 5.5.1. Acute Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. Sports Injuries
    • 5.5.2.1 Sports Injuries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3 Postoperative Pain
    • 5.5.3.1 Postoperative Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.4 Labor Pain
    • 5.5.4.1 Labor Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.5 Menstrual Pain
    • 5.5.5.1 Menstrual Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Transcutaneous Electrical Nerve Stimulation Market: End-use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Transcutaneous Electrical Nerve Stimulation Market Movement Analysis
• 6.3. Global Transcutaneous Electrical Nerve Stimulation Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Physiotherapy Clinics
  • 6.5.1. Physiotherapy Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Rehabilitation Centers
  • 6.6.1. Rehabilitation Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Home Care
  • 6.7.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Others
  • 6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Transcutaneous Electrical Nerve Stimulation Market: Regional Estimates & Trend Analysis By Product Type, By End-use, By Application

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. North America Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Scenario
    • 7.3.2.4. Reimbursement Scenario
    • 7.3.2.5. U.S. Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Scenario
    • 7.3.3.4. Reimbursement Scenario
    • 7.3.3.5. Canada Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Scenario
    • 7.4.2.4. Reimbursement Scenario
    • 7.4.2.5. UK Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Scenario
    • 7.4.3.4. Reimbursement Scenario
    • 7.4.3.5. Germany Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Scenario
    • 7.4.4.4. Reimbursement Scenario
    • 7.4.4.5. France Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Scenario
    • 7.4.5.4. Reimbursement Scenario
    • 7.4.5.5. Italy Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Scenario
    • 7.4.6.4. Reimbursement Scenario
    • 7.4.6.5. Spain Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Scenario
    • 7.4.7.4. Reimbursement Scenario
    • 7.4.7.5. Denmark Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Scenario
    • 7.4.8.4. Reimbursement Scenario
    • 7.4.8.5. Sweden Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Scenario
    • 7.4.9.4. Reimbursement Scenario
    • 7.4.9.5. Norway Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Scenario
    • 7.5.2.4. Reimbursement Scenario
    • 7.5.2.5. Japan Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Scenario
    • 7.5.3.4. Reimbursement Scenario
    • 7.5.3.5. China Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Scenario
    • 7.5.4.4. Reimbursement Scenario
    • 7.5.4.5. India Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Scenario
    • 7.5.5.4. Reimbursement Scenario
    • 7.5.5.5. South Korea Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Scenario
    • 7.5.6.4. Reimbursement Scenario
    • 7.5.6.5. Australia Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Scenario
    • 7.5.7.4. Reimbursement Scenario
    • 7.5.7.5. Thailand Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Scenario
    • 7.6.2.4. Reimbursement Scenario
    • 7.6.2.5. Brazil Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Mexico
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Scenario
    • 7.6.3.4. Reimbursement Scenario
    • 7.6.3.5. Mexico Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. Argentina
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Scenario
    • 7.6.4.4. Reimbursement Scenario
    • 7.6.4.5. Argentina Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Middle East & Africa
  • 7.7.1. Middle East & Africa Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Scenario
    • 7.7.2.4. Reimbursement Scenario
    • 7.7.2.5. South Africa Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Scenario
    • 7.7.3.4. Reimbursement Scenario
    • 7.7.3.5. Saudi Arabia Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Scenario
    • 7.7.4.4. Reimbursement Scenario
    • 7.7.4.5. UAE Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Scenario
    • 7.7.5.4. Reimbursement Scenario
    • 7.7.5.5. Kuwait Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. OMRON CORPORATION
    • 8.2.1.1. Company Overview
    • 8.2.1.2. Financial Performance
    • 8.2.1.3. Service Benchmarking
    • 8.2.1.4. Strategic Initiatives
  • 8.2.2. ZYNEX MEDICAL
    • 8.2.2.1. Company Overview
    • 8.2.2.2. Financial Performance
    • 8.2.2.3. Service Benchmarking
    • 8.2.2.4. Strategic Initiatives
  • 8.2.3. NEUROMETRIX, INC.
    • 8.2.3.1. Company Overview
    • 8.2.3.2. Financial Performance
    • 8.2.3.3. Product Benchmarking
    • 8.2.3.4. Strategic Initiatives
  • 8.2.4. EMS PHYSIO LTD.
    • 8.2.4.1. Company Overview
    • 8.2.4.2. Financial Performance
    • 8.2.4.3. Product Benchmarking
    • 8.2.4.4. Strategic Initiatives
  • 8.2.5. BIOMEDICAL LIFE SYSTEMS
    • 8.2.5.1. Company Overview
    • 8.2.5.2. Financial Performance
    • 8.2.5.3. Product Benchmarking
    • 8.2.5.4. Strategic Initiatives
  • 8.2.6. DJO GLOBAL, INC.
    • 8.2.6.1. Company Overview
    • 8.2.6.2. Financial Performance
    • 8.2.6.3. Product Benchmarking
    • 8.2.6.4. Strategic Initiatives
  • 8.2.7. GLOBUS
    • 8.2.7.1. Company Overview
    • 8.2.7.2. Financial Performance
    • 8.2.7.3. Product Benchmarking
    • 8.2.7.4. Strategic Initiatives
  • 8.2.8. Beacmed s.r.l.
    • 8.2.8.1. Company Overview
    • 8.2.8.2. Financial Performance
    • 8.2.8.3. Product Benchmarking
    • 8.2.8.4. Strategic Initiatives
  • 8.2.9. Iskra Medical d.o.o.
    • 8.2.9.1. Company Overview
    • 8.2.9.2. Financial Performance
    • 8.2.9.3. Product Benchmarking
    • 8.2.9.4. Strategic Initiatives
  • 8.2.10. Ito Co., Ltd.
    • 8.2.10.1. Company Overview
    • 8.2.10.2. Financial Performance
    • 8.2.10.3. Product Benchmarking
    • 8.2.10.4. Strategic Initiatives
• 8.3. Heat Map Analysis/ Company Market Position Analysis
• 8.4. Estimated Company Market Share Analysis, 2023
• 8.5. List of Other Key Market Players

관련자료